HIIFS
AMRX icon

Harel Insurance Investments & Financial Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,502
Closed -$33K – 698
2022
Q2 		$33K Buy
10,502
+2,688
+34% +$9.74K ﹤0.01% 573
2022
Q1 		$33K Sell
7,814
-574
-7% -$2.54K ﹤0.01% 583
2021
Q4 		$41K Buy
8,388
+2,979
+55% +$14.9K ﹤0.01% 616
2021
Q3 		$29K Buy
+5,409
New +$27.2K ﹤0.01% 579

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harel Insurance Investments & Financial Services's AMRX Position: Q3 2022 in Review

Harel Insurance Investments & Financial Services sold out of Amneal Pharmaceuticals (AMRX) in Q3 2022, closing a stake of 10,502 shares — an estimated $33K sold.

Harel Insurance Investments & Financial Services first reported a position in AMRX in Q3 2021 and held it in 4 quarters. The position peaked at $41K in Q4 2021. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2022.

  • Harel Insurance Investments & Financial Services reported no remaining Amneal Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 10,502 Amneal Pharmaceuticals shares in Q3 2022, an estimated $33K.
  • Harel Insurance Investments & Financial Services first reported a position in Amneal Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's Amneal Pharmaceuticals position peaked at $41K in Q4 2021.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2022, filed 31 Oct 2022.